PRAX241220P65000
- 3.39
- 0.000.00%
Praxis Precision Medicines Newsroom
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270
Piper Sandler Gives a Buy Rating to Praxis Precision Medicines (PRAX)
A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $114 to $120
Praxis Precision Medicines: Strong Buy Rating Amid Potential Upside and Robust Pipeline Despite Operational Challenges
A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $114 to $170
Praxis Precision Med Price Target Maintained With a $151.00/Share by Needham
Praxis Precision Medicine Analyst Ratings
Wedbush Raises Praxis Precision Medicines Price Target to $57 From $51, Maintains Neutral Rating
Praxis Precision Med Is Maintained at Outperform by Oppenheimer
Praxis Precision Medicine Analyst Ratings
Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $163
Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $143
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270
Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating
Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating
Truist Financial Remains a Buy on Praxis Precision Medicines (PRAX)
TD Cowen Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating
Praxis Precision Medicines (PRAX) Receives a Buy From TD Cowen
Praxis Precision Medicine Analyst Ratings
H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $120